Under the leadership of Prime Minister Narendra Modi, the Indian government has shown that it understands the need to develop innovation in the country’s health care sector.
Baltimore was a major site in the effort to develop an Ebola vaccine. Two years later, a leading Johns Hopkins researcher is looking to apply a major discovery to the Zika virus.
J. Thomas August, a JHU pharmacology and molecular sciences professor, formed Pharos Biologicals in December. The company received a license to develop DNA vaccine technology called the LAMP for influenza and flaviviruses from the Johns Hopkins School of Medicine.
GlaxoSmithKline CEO Andrew Witty attributes the company’s success to sticking to the tried-and-true business model of investing in research and development and not transitioning to an acquisition model.
Witty told CNBC’s “Closing Bell” on Monday that the key is to be patient and to see the value of investing in innovation.
Lita Nelsen is one of the most influential power brokers in the drug industry — and yet there’s a good chance you’ve never heard of her.
That’s because she ran one of the country’s largest and most successful technology transfer offices, an unglamorous yet essential go-between for universities and startups. And any time a venture capitalist, a pharmaceutical company, or a tech titan wanted to cash in on an invention at the Massachusetts Institute of Technology, each had to go through her.
Orthopedic surgeons are relying more and more on 3-D printing to build replacements for their patients’ defective or worn out bones.
This year surgeons around the world will implant tens of thousands of 3-D printed replacements parts for hips, knees, ankles, parts of the spine, and even sections of the skull.
As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders (D-VT) and others urging that the march in provision of the Bayh-Dole Act be used to control drug prices, it’s worthwhile to recall the time the agency followed similar advice. That resulted in a smack down by Congress and the courts after a band of universities, an innovative small company and a conscientious federal employee refused to be bullied, altering the course of government.
Thursday, May 26, 2016
Please join us for the award ceremony where we announce the three winners of the Innovation into Action Challenge—a new initiative to support innovations with the potential to make a difference in the lives of people in emerging nations. At stake is a tailored package of support designed to accelerate the winning innovations’ deployment in the field, including $100,000 in funding, market testing on DAI’s overseas projects, access to a network of accelerator professionals, and technical mentoring to refine the innovator’s pitch, product, or service.
Today, Stewart Edelstein, executive director of the Universities at Shady Grove, released the following statement:
“On behalf of the entire Universities at Shady Grove (USG) community, I want to thank the Maryland General Assembly and Governor Hogan for reinstating $36.7 million in funding for the construction of our Biomedical Sciences and Engineering Education (BSE) facility. With this secured funding, the Universities at Shady Grove plans to break ground later this year on the new facility.
Maryland got an infusion of West Coast tech money recently. It’s going toward a new spot for College Park students to study the latest in digital technology.
Oculus CEO Brendan Iribe provided $31 million to the University of Maryland College Park. The 36-year-old’s name is now on the school’s new Center for Computer Science and Innovation. Iribe’s fellow cofounders are also included in the naming of the center, who gave a combined $7 million. It will include the 300-seat Michael Antonov Auditorium and a rooftop garden called Andrew Reisse Park.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- Notice of Changes in Expiration Date of Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
- (NOT-OD-16-085) National Institutes of Health
- Notice of Correction of the Funding Opportunity Announcement Number for RFA-OD-16-007 “Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Center Grants (P51)”
- (NOT-OD-16-086) Division of Program Coordination, Planning and Strategic
- Initiatives, Office of Research Infrastructure ProgramsImproving Physical Infrastructure to Enhance Animal Model Research: Revisions of Center Grants (P51)
- (RFA-OD-16-007)
- Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Application Receipt Date(s): August 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
- Improving Physical Infrastructure to Enhance Animal Model Research: Revisionsof Research Project Grants (R01)
- (RFA-OD-16-008)
- Division of Program Coordination, Planning and Strategic Initiatives, Office of
- Research Infrastructure Programs
- Application Receipt Date(s): August 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
- Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Research Project Grants (R24)
- (RFA-OD-16-009)
- Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Application Receipt Date(s): August 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.